Cancer patients under active chemotherapy are more vulnerable to coronavirus disease 19 (COVID-19). There are still some controversies regarding routine polymerase chain reaction testing of asymptomatic cancer patients before chemotherapy cycles. Despite a lack of data, Al-Shamsi et al. showed higher COVID-19 positivity rate among asymptomatic cancer patients. Furthermore, mortality rate was higher in this group of patients. There is no high evidence-based recommendation from the cancer societies for testing asymptomatic patients before each chemotherapy cycle. In this commentary, we assessed the current publications and guidelines regarding this issue.
MehtaVGoelSKabarritiR, et al.
Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov2020;
10: 935–941.
2.
WuZMcGooganJM.Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. Jama2020;
323: 1239–1242.
3.
KudererNMChoueiriTKShahDP, et al.
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. The Lancet2020;
395: 1907–1918.
4.
Lee LYW, Cazier JB, Starkey T, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol 2020; 21: 1309--1316.
5.
Yekeduz E, Utkan G and Urun Y. A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19. Eur J Cancer 2020; 141: 92--104.
6.
ShahMAMayerSEmlenF, et al.
Clinical screening for COVID-19 in asymptomatic patients with cancer. JAMA Netw Open2020;
3: e2023121.
7.
YinPZengRDuanYR, et al.
An analysis of cancer patients with asymptomatic infection of SARS-CoV-2 in a cancer center in Wuhan, China. Ann Oncol2020;
31: 1420–1422.
8.
Al-ShamsiHOCoomesEAAlrawiS.Screening for COVID-19 in asymptomatic patients with cancer in a hospital in the United Arab Emirates. JAMA Oncol2020;
6: 1627–1628.
9.
Al-ShamsiHOCoomesEAAldhaheriK, et al.
Serial screening for COVID-19 in asymptomatic patients receiving anticancer therapy in the United Arab Emirates. JAMA Oncol2020: e205745
CuriglianoGBanerjeeSCervantesA, et al.
Managing cancer patients during the COVID-19 pandemic: an ESMO interdisciplinary expert consensus. Ann Oncol2020;
31: 1320–1335.
ÜrünYHussainSABakounyZ, et al.
Survey of the impact of COVID-19 on oncologists’ decision making in cancer. JCO Global Oncol2020;
6: 1248–1257.
14.
Hempel L, Piehler A, Pfaffl MW, et al. SARS-CoV-2 infections in cancer outpatients-Most infected patients are asymptomatic carriers without impact on chemotherapy. Cancer Med 2020; 9: 8020--8028.
